Cargando…
Corrigendum: Receptor of advanced glycation end products deficiency attenuates cisplatin-induced acute nephrotoxicity by inhibiting apoptosis, inflammation and restoring fatty acid oxidation
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664383/ https://www.ncbi.nlm.nih.gov/pubmed/36386170 http://dx.doi.org/10.3389/fphar.2022.1022539 |
_version_ | 1784831088368025600 |
---|---|
author | Wang, Qiang Xi, Yuemei Chen, Binyang Zhao, Hairong Yu, Wei Xie, De Liu, Weidong He, Furong Xu, Chenxi Cheng, Jidong |
author_facet | Wang, Qiang Xi, Yuemei Chen, Binyang Zhao, Hairong Yu, Wei Xie, De Liu, Weidong He, Furong Xu, Chenxi Cheng, Jidong |
author_sort | Wang, Qiang |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9664383 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96643832022-11-15 Corrigendum: Receptor of advanced glycation end products deficiency attenuates cisplatin-induced acute nephrotoxicity by inhibiting apoptosis, inflammation and restoring fatty acid oxidation Wang, Qiang Xi, Yuemei Chen, Binyang Zhao, Hairong Yu, Wei Xie, De Liu, Weidong He, Furong Xu, Chenxi Cheng, Jidong Front Pharmacol Pharmacology Frontiers Media S.A. 2022-11-01 /pmc/articles/PMC9664383/ /pubmed/36386170 http://dx.doi.org/10.3389/fphar.2022.1022539 Text en Copyright © 2022 Wang, Xi, Chen, Zhao, Yu, Xie, Liu, He, Xu and Cheng. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Wang, Qiang Xi, Yuemei Chen, Binyang Zhao, Hairong Yu, Wei Xie, De Liu, Weidong He, Furong Xu, Chenxi Cheng, Jidong Corrigendum: Receptor of advanced glycation end products deficiency attenuates cisplatin-induced acute nephrotoxicity by inhibiting apoptosis, inflammation and restoring fatty acid oxidation |
title | Corrigendum: Receptor of advanced glycation end products deficiency attenuates cisplatin-induced acute nephrotoxicity by inhibiting apoptosis, inflammation and restoring fatty acid oxidation |
title_full | Corrigendum: Receptor of advanced glycation end products deficiency attenuates cisplatin-induced acute nephrotoxicity by inhibiting apoptosis, inflammation and restoring fatty acid oxidation |
title_fullStr | Corrigendum: Receptor of advanced glycation end products deficiency attenuates cisplatin-induced acute nephrotoxicity by inhibiting apoptosis, inflammation and restoring fatty acid oxidation |
title_full_unstemmed | Corrigendum: Receptor of advanced glycation end products deficiency attenuates cisplatin-induced acute nephrotoxicity by inhibiting apoptosis, inflammation and restoring fatty acid oxidation |
title_short | Corrigendum: Receptor of advanced glycation end products deficiency attenuates cisplatin-induced acute nephrotoxicity by inhibiting apoptosis, inflammation and restoring fatty acid oxidation |
title_sort | corrigendum: receptor of advanced glycation end products deficiency attenuates cisplatin-induced acute nephrotoxicity by inhibiting apoptosis, inflammation and restoring fatty acid oxidation |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664383/ https://www.ncbi.nlm.nih.gov/pubmed/36386170 http://dx.doi.org/10.3389/fphar.2022.1022539 |
work_keys_str_mv | AT wangqiang corrigendumreceptorofadvancedglycationendproductsdeficiencyattenuatescisplatininducedacutenephrotoxicitybyinhibitingapoptosisinflammationandrestoringfattyacidoxidation AT xiyuemei corrigendumreceptorofadvancedglycationendproductsdeficiencyattenuatescisplatininducedacutenephrotoxicitybyinhibitingapoptosisinflammationandrestoringfattyacidoxidation AT chenbinyang corrigendumreceptorofadvancedglycationendproductsdeficiencyattenuatescisplatininducedacutenephrotoxicitybyinhibitingapoptosisinflammationandrestoringfattyacidoxidation AT zhaohairong corrigendumreceptorofadvancedglycationendproductsdeficiencyattenuatescisplatininducedacutenephrotoxicitybyinhibitingapoptosisinflammationandrestoringfattyacidoxidation AT yuwei corrigendumreceptorofadvancedglycationendproductsdeficiencyattenuatescisplatininducedacutenephrotoxicitybyinhibitingapoptosisinflammationandrestoringfattyacidoxidation AT xiede corrigendumreceptorofadvancedglycationendproductsdeficiencyattenuatescisplatininducedacutenephrotoxicitybyinhibitingapoptosisinflammationandrestoringfattyacidoxidation AT liuweidong corrigendumreceptorofadvancedglycationendproductsdeficiencyattenuatescisplatininducedacutenephrotoxicitybyinhibitingapoptosisinflammationandrestoringfattyacidoxidation AT hefurong corrigendumreceptorofadvancedglycationendproductsdeficiencyattenuatescisplatininducedacutenephrotoxicitybyinhibitingapoptosisinflammationandrestoringfattyacidoxidation AT xuchenxi corrigendumreceptorofadvancedglycationendproductsdeficiencyattenuatescisplatininducedacutenephrotoxicitybyinhibitingapoptosisinflammationandrestoringfattyacidoxidation AT chengjidong corrigendumreceptorofadvancedglycationendproductsdeficiencyattenuatescisplatininducedacutenephrotoxicitybyinhibitingapoptosisinflammationandrestoringfattyacidoxidation |